2016

1. A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck

   International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 2, pp. 289-296